Skip to main content
. 2022 Mar 31;12:800481. doi: 10.3389/fphar.2021.800481

TABLE 1.

Summary of liposome-targeted CD44 cells for cancer therapy.

Types of liposomes Therapeutic agents Types of cancer X′ cell lines Animal model References
HA-modified liposomes DOX and PTX Breast cancer MCF-7 and HepG2 Song et al. (2019)
Cationic liposomes Cabazitaxel and silibinin Prostate cancer PC-3 and DU-145 Mahira et al. (2019)
Cationic liposomes Gemcitabine and docetaxel TNBC MCF-7 and MDA-MB-231 Mice Fan et al. (2017)
PEGylated liposomes Anti-CD44 2′-F pyrimidine RNA aptamer Lung and breast A549 and MDA-MB-231 Alshaer et al. (2015)
HNPs Paclitaxel Metastatic breast cancer 4T1, MCF-7, A549, and NIH/3T3 cells Mice Lv et al. (2018)
PEGylated liposomes Stigmasterol and DOX Breast cancer MCF-7 and MDA-MB-231 Mice Gautam et al. (2020)
Polymersomes (PEG-PCL) DOX Breast cancer MCF-7 and 4T1 Mice Shahriari et al. (2019)